Lifecore Biomedical Inc (LFCR) Noticias

Form DEF 14A - Other definitive proxy statements

Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Form PRE 14A - Other preliminary proxy statements

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Lifecore Biomedical Announces Special Stockholder Meeting

CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Form 8-K - Current report

Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to...

Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference

CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report